Chronic hyperglycemia impairs functional vasodilation via increasing thromboxane-receptor-mediated vasoconstriction

Area of Science:

• Cardiovascular Physiology
• Endocrinology
• Metabolic Disorders

Background:

• Hyperglycemia in diabetes is linked to impaired exercise performance and reduced functional vasodilation.
• Arachidonic acid (AA) metabolites are crucial for vasodilation, and diabetes alters the balance towards vasoconstriction.
• The thromboxane-to-prostacyclin ratio is elevated in diabetes, suggesting a role for thromboxane receptors (TP) in endothelial dysfunction.

Purpose of the Study:

• To investigate if chronic hyperglycemia increases TP-mediated vasoconstriction, leading to attenuated functional vasodilation in diabetic rats.
• To determine the effect of a TP antagonist on vasodilation in a diabetic rat model.

Main Methods:

• Lean Zucker rats were divided into normal, streptozotocin (STZ)-induced diabetic, and STZ + insulin groups.
• After 4 weeks, spinotrapezius arcade arterioles were studied for microcirculatory responses.
• Arteriolar diameter changes were measured during muscle stimulation and AA application, with and without a TP antagonist (SQ-29548).

Main Results:

• STZ rats showed higher glucose levels and significantly reduced functional and AA-induced vasodilation compared to controls.
• The TP antagonist SQ-29548 improved vasodilation in STZ rats but not in normal rats.
• Insulin treatment normalized glucose levels and restored normal vasodilatory responses, rendering SQ-29548 ineffective.

Conclusions:

• Hyperglycemia in diabetes exacerbates vasoconstriction through TP-mediated pathways.
• Targeting TP-mediated vasoconstriction may be a therapeutic strategy to improve endothelial function and exercise capacity in diabetes.
• Restoration of normal glucose metabolism effectively reverses the detrimental effects on vasodilation.